Endo International PLC (ENDP)

pos +0.00
Today's Range: 85.04 - 87.69 | ENDP Avg Daily Volume: 2,279,100
Last Update: 07/31/15 - 3:59 PM EDT
Volume: 0
YTD Performance: 21.38%
Open: $0.00
Previous Close: $85.96
52 Week Range: $57.14 - $96.58
Oustanding Shares: 178,746,233
Market Cap: 15,365,026,189
6-Month Chart
TheStreet Ratings Grade for ENDP
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 6 8 8
Moderate Buy 1 2 2 2
Hold 4 5 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.71 1.88 1.68 1.68
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -23.23
Price Earnings Comparisons:
ENDP Sector Avg. S&P 500
-23.23 0.00 25.63
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
4.13% 30.50% 194.45%
Revenue 9.90 0.05 0.02
Net Income 0.00 -3.99 0.00
EPS 0.00 -4.05 0.00
Earnings for ENDP:
Revenue 2.88B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.02 $1.10 $4.49 $5.41
Number of Analysts 6 6 8 8
High Estimate $1.09 $1.19 $4.57 $5.90
Low Estimate $0.97 $0.93 $4.34 $4.89
Prior Year $1.06 $1.15 $4.31 $4.49
Growth Rate (Year over Year) -3.46% -4.49% 4.26% 20.31%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Jul 17, 2015 | 7:11 AM EDT
ENDP was upgraded from Outperform to Top Pick, RBC Capital said. $107 price target. Company is attractively valued and consensus number...
Acquisitions cut into overabundance of companies.
Endo Pharmaceuticals could offer a short-term play.
Apr 13, 2015 | 8:15 AM EDT
Shares of ENDP now seen reaching $96, according to Deutsche Bank. Estimates also upped, as Xiaflex should drive growth. Buy rating.&nbs...
Take a look at some more of its recent moves.
It's wise to stick with strength right now.

Merger Mania Benefits Mylan Real Money Pro($)

Whether it's acquiring or the acquired, Mylan is building shareholder value.
Oct 13, 2014 | 7:54 AM EDT
ENDP upgraded to Hold, said Cantor Fitzgerald. Auxilium deal should be accretive to EPS with longer term increases in EBITDA, possibly ...
May 02, 2014 | 8:10 AM EDT
ENDP was upgraded from Equal-weight to Overweight, Morgan Stanley said. $79 price target. Mesh settlement removes a multi-billion dolla...
Mar 03, 2014 | 7:47 AM EST
ENDP bumped up its number, UBS said. Driven by continud performance of base business and potential for accretive deals. $90 price targe...

Columnist Conversations

As the Fed's interest rate hike is approaching, it's high yield debt that is suffering the most, posting big o...
The Athens exchange which opened today after a forced closure of over a month due to the crisis opened down 23...
Chinese factory activity in July fell to a two year low as the stock market flash crash more than likely put a...


News Breaks

Powered by

Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.